Indian Immunologicals’ subsidiary in New Zealand lives up to its promise

New Delhi: Pristine Biologicals (NZ) Ltd (PBNL), a subsidiary of Indian Immunologicals Limited (IIL) established in Dargaville, New Zealand has played a major role in providing key raw materials used in vaccine manufacture in India.

From humble beginnings as a backward integration project, Pristine has grown into as a self-sustainable unit and consistent supplier of quality raw materials.

Pristine Biologicals celebrated its 10th anniversary on 7th November, as a successfully operated facility in an event in Dargaville, New Zealand. Mr Andrew Hoggard, Hon’ble Minister for Bio Security, Environment and Associate Minister for Agriculture graced the occasion as Chief Guest.Hon.Jonathan Larsen –  Mayor of Dargaville, Dr Meenesh C Shah – Chairman of National Dairy Development Board, IIL and Pristine, Dr K Anand Kumar – MD, IIL and Director Pristine, Ms.Julie Collins – DDG Policy and Trade, MPI, Dr. Mary Vandel – CVO, MPI, Dr Vijay Dasari – Resident Director of Pristine, S.Rajeev, Director IIL, Dr. Devanand – Director IIL, Dr Santosh B Ghadage – Sr Vice President IIL and many dignitaries including officials from the Indian consulate, business leaders were present on the occasion.

Speaking on the occasion, commemorating the 10th anniversary of Pristine Biologicals in Dargaville, New Zealand, Dr Meenesh C Shah, Chairman – National Dairy Development Board said “ Today the world looks at India as a vaccine manufacturing hub for prevention of diseases and for global good. Pristine biologicals has been a reliable supplier of quality ingredients for making vaccines in India and this has enabled our resolve for “Atma nirbhar”

Speaking on the occasion, Dr K Anand Kumar, MD, Indian Immunologicals said “It’s a very satisfying moment for us as a team as Pristine celebrates its tenth anniversary today. As a quality vaccine manufacturer, IIL sources the best of ingredients from across the globe and Pristine was born as a result of our desire to secure key raw materials used in vaccine manufacturing. In these 10 years, using supplies from Pristine, millions of doses of animal and human vaccines have been made in our vaccine manufacturing plants in India, saving many million lives. I congratulate the team at Dargaville for the effort and wish them greater success for the future. I thank our partners SFF for this win-win partnership”.

IIL’s strategic entry into New Zealand was to source and secure high quality ingredients and hence entered into an agreement with Silver Fern Farms (SFF). New Zealand is free from WOAH listed animal diseases and hence animal products of New Zealand origin command a premium in the world markets, The Pristine manufacturing facility was established in Dargaville in Northland adjacent to the SFF facility as this enables speedy processing and in a manner such that the goodness of the ingredients are preserved.  The entire serum needs of IIL in India is met by Pristine. The company has already exported about 2800000 tonnes of ABS and NBCS so far and this has helped in the production of over 2 billion doses of animal and human vaccines back in India. Pristine also supplies serum to vaccine manufacturers in other countries like Australia, Turkey etc.

In the year 2024, PBNL was conferred with prestigious Business Excellence Award for Marketing and Business Excellence Award in International Trade with India. The awards were handed over by Mr Christopher Luxon, Hon’ble Prime Minister of New Zealand.